Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 β-lactamases co-mediated by porin loss
- 28 February 2007
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 29 (2), 201-206
- https://doi.org/10.1016/j.ijantimicag.2006.09.006
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prevalence of Plasmid-mediated AmpCβ-Lactamases inEscherichia coliandKlebsiella pneumoniaein KoreaMicrobial Drug Resistance, 2006
- Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC β-lactamases–producing isolates of Escherichia coli and Klebsiella pneumoniaeDiagnostic Microbiology and Infectious Disease, 2005
- In Vivo Transfer of Plasmid-Encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an Infant and Selection of Impermeability to Imipenem in K. pneumoniaeAntimicrobial Agents and Chemotherapy, 2005
- Practical Methods Using Boronic Acid Compounds for Identification of Class C β-Lactamase-ProducingKlebsiella pneumoniaeandEscherichia coliJournal of Clinical Microbiology, 2005
- Metallo-β-Lactamases: the Quiet before the Storm?Clinical Microbiology Reviews, 2005
- Role of Klebsiella pneumoniae OmpK35 Porin in Antimicrobial ResistanceAntimicrobial Agents and Chemotherapy, 2003
- Plasmid-Determined AmpC-Type β-LactamasesAntimicrobial Agents and Chemotherapy, 2002
- Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alterationJournal of Antimicrobial Chemotherapy, 2000
- Roles of β-Lactamases and Porins in Activities of Carbapenems and Cephalosporins against Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1999
- Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity FactorsClinical Microbiology Reviews, 1998